In this issue:
Efficacy and safety of extracranial vein angioplasty in MS
ECTRIMS/EAN guideline on the pharmacological treatment of MS
Cortical and DGM functional connectivity changes in MS
MS risk variants alter expression of co-stimulatory genes in B cells
Treatment of MS relapses with IVMP reduces the evolution of contrast-enhancing lesions into persistent black holes
Amantadine treatment to improve walking in MS
Psychological determinants of job retention in MS
MRI changes following natalizumab discontinuation in MS patients with PML
Long-term effects of cladribine on MRI activity outcomes in RRMS
Olfactory function as a marker of inflammatory activity and disability progression in MS
Please login below to download this issue (PDF)